Authors
Loading...
This perspective demonstrates how multiomics and machine learning improve drug development and clinical decision-making in antimicrobial resistance.
Arun et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: